Article

Living with coeliac disease and a gluten-free diet: a Canadian perspective

Canadian Celiac Association, Professional Advisory Board, Mississauga, ON, Canada.
Journal of Human Nutrition and Dietetics (Impact Factor: 2.07). 11/2012; 26(1). DOI: 10.1111/j.1365-277X.2012.01288.x
Source: PubMed

ABSTRACT OBJECTIVE: Strict adherence to a gluten-free diet is the only treatment for coeliac disease. The gluten-free diet is complex, costly and impacts on all activities involving food, making it difficult to maintain for a lifetime. The purpose of this cross-sectional study was to evaluate the difficulties experienced, the strategies used and the emotional impact of following a gluten-free diet among Canadians with coeliac disease. METHODS: A questionnaire was mailed to all members (n = 10 693) of both the Canadian Celiac Association and the Fondation québécoise de la maladie cœliaque in 2008. RESULTS: The overall response rate was 72%. Results are presented for the 5912 respondents (≥18 years) reporting biopsy-confirmed coeliac disease and/or dermatitis herpetiformis. Two-thirds never intentionally consumed gluten. Women reported significantly greater emotional responses to a gluten-free diet but, with time, were more accepting of it than men. Difficulties and negative emotions were experienced less frequently by those on the diet for >5 years, although food labelling and eating away from home remained very problematic. Frustration and isolation because of the diet were the most common negative emotions experienced. CONCLUSIONS: The present study quantifies the difficulties experienced, the strategies used and the emotional impact of following a gluten-free diet. It highlights the need to improve the training and education of dietitians, other health providers and the food service industry workers about coeliac disease and a gluten-free diet, with the aim of better helping individuals improve their adherence to a gluten-free diet and their quality of life.

Download full-text

Full-text

Available from: Olga M Pulido, Oct 19, 2014
1 Follower
 · 
108 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Celiac disease can present with mild or nongastrointestinal symptoms, and may escape timely recognition. The treatment of celiac disease involves a gluten-free diet, which is complex and challenging. To evaluate clinical features and symptom recovery on a gluten-free diet in a Canadian adult celiac population. All adult members (n=10,693) of the two national celiac support organizations, the Canadian Celiac Association and Fondation québécoise de la maladie coeliaque, were surveyed using a questionnaire. A total of 5912 individuals (≥18 years of age) with biopsy-confirmed celiac disease and⁄or dermatitis herpetiformis completed the survey. The female to male ratio was 3:1, and mean (± SD) age at diagnosis was 45.2±16.4 years. Mean time to diagnosis after onset of symptoms was 12.0±14.4 years. Abdominal pain and bloating (84.9%), extreme weakness⁄tiredness (74.2%), diarrhea (71.7%) and anemia (67.8%) were the most commonly reported symptoms at the time of diagnosis. Many respondents continued to experience symptoms after being on a gluten-free diet for >5 years. Sex differences were reported in clinical features before diagnosis, recovery after being on gluten-free diet and perceived quality of life, with women experiencing more difficulties than men. Delays in diagnosis of celiac disease in Canada remain unacceptably long despite wider availability of serological screening tests. Many patients report continuing symptoms despite adhering to a gluten-free diet for >5 years, with women experiencing more symptoms and a lower recovery rate than men. Awareness of celiac disease needs improvement, and follow-up with a physician and a dietitian is essential for all patients with celiac disease.
    08/2013; 27(8):449-53.
  • [Show abstract] [Hide abstract]
    ABSTRACT: A large national investigation into the extent of gluten cross-contamination of naturally gluten-free ingredients (flours and starches) sold in Canada was performed. Samples (n = 640) were purchased from eight Canadian cities and via the internet during the period 2010-2012 and analysed for gluten contamination. The results showed that 61 of the 640 (9.5%) samples were contaminated above the Codex-recommended maximum level for gluten-free products (20 mg kg(-1)) with a range of 5-7995 mg kg(-1). For the ingredients that were labelled gluten-free the contamination range (5-141 mg kg(-1)) and number of samples were lower (3 of 268). This picture was consistent over time, with approximately the same percentage of samples above 20 mg kg(-1) in both the initial set and the subsequent lot. Looking at the total mean (composite) contamination for specific ingredients the largest and most consistent contaminations come from higher fibre ingredients such as soy (902 mg kg(-1)), millet (272 mg kg(-1)) and buckwheat (153 mg kg(-1)). Of the naturally gluten-free flours and starches tested that do not contain a gluten-free label, the higher fibre ingredients would constitute the greatest probability of being contaminated with gluten above 20 mg kg(-1).
    Food Additives and Contaminants - Part A Chemistry, Analysis, Control, Exposure and Risk Assessment 10/2013; 30(12). DOI:10.1080/19440049.2013.840744 · 2.34 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This chapter explains the ttle of the book and highlights the importance of recognizing the Nonceliac Gluten Sensitvity. Briefy discuss the topics covered in the diferent chapters within the context of a new defniton with recent advances in China, Mexico, El Salvador and Costa Rica. We review the immunological diferences between celiac disease and non-celiac gluten sensitvity as well as the clinical and pathological diferences among celiac disease, gluten allergy, gluten sensitvity and non-celiac gluten intolerance. The physiological and immunological efects that can trigger wheat products are also briefy summarized without mentoning somatzaton disorders that may apply to some patents with sensitvity or food intolerance. In this light we describe new concepts over placebo and nocebo. This new insight suggests the need to incorporate protocols to understand the efects of a gluten-free diet. It is clear that the two opposing mechanisms, placebo and nocebo may be important not only when administering drugs but when specifc diets are used as a treatment. Subsequently, attenton is drawn to the chapters of diagnostc techniques such as celiac disease serology, endoscopy and histopathology as well as various clinical forms in children and adults. Finally, we briefy review the diferent and clinically important topics in celiac disease that is described by authors that are experts in their respectve issues.